Lv31
338 积分 2023-01-10 加入
The very druggable RAS proteins
5分钟前
待确认
The evolving landscape of RAS-targeted therapies
9分钟前
已完结
TALENTOP study: a new era for conversion surgery in advanced hepatocellular carcinoma?
16天前
已完结
On-demand transarterial chemoembolisation combined with atezolizumab and bevacizumab in patients with untreated hepatocellular carcinoma (TALENTACE): a multicentre, randomised, open-label, phase 3 trial
2个月前
已完结
On-demand transarterial chemoembolisation combined with atezolizumab and bevacizumab in patients with untreated hepatocellular carcinoma (TALENTACE): a multicentre, randomised, open-label, phase 3 trial
2个月前
已完结
Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial
2个月前
已完结
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update Clinical Insights
2个月前
已关闭
Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial
2个月前
已完结
Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial
2个月前
已完结
TALENTOP study: a new era for conversion surgery in advanced hepatocellular carcinoma?
2个月前
已完结
皖公网安备34019202002308
